EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Introduction of a single carboxylic acid converts the cyclic oligomeric depsipeptide ent-verticilide from a ryanodine receptor 2 (RyR2) inhibitor to RyR2 activator

Tri Q Do, Daniel J Blackwell, Abigail N Smith, Madelaine P Thorpe, Robyn T Rebbeck, Derek R Laver, Jeffrey N Johnston, Björn C Knollmann

Molecular Pharmacology · 2025-12 · 107 (12) · 100086

DOI: 10.1016/j.molpha.2025.100086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmacology, 2025-12. Verfasst von Tri Q Do und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt Center for Arrhythmia Research and Therapeutics, Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical …. Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Depsipeptides, Carboxylic Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health, National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ryanodine Receptor Calcium Release ChannelDepsipeptidesCarboxylic AcidsAnimalsHumansMiceHEK293 Cells

Stichwörter der Autor:innen

Calcium release deficiency syndromeCardiac arrhythmiaCatecholaminergic polymorphic ventricular tachycardiaCyclic oligomeric depsipeptidesRyanodine receptorStructure-activity relationship

Substanzen

Ryanodine Receptor Calcium Release ChannelDepsipeptidesCarboxylic Acids

Autor:innen und Institutionen

  • Vanderbilt Center for Arrhythmia Research and Therapeutics, Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Department of Chemistry, Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee.
  • Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, Minnesota.
  • Vanderbilt Center for Arrhythmia Research and Therapeutics, Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: bjorn.knollmann@vand…

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health
  • National Heart Lung and Blood Institute
  • American Heart Association Inc

Zitieren

APA

Do, T. Q., Blackwell, D. J., Smith, A. N., Thorpe, M. P., Rebbeck, R. T., Laver, D. R., Johnston, J. N., & Knollmann, B. C. (2025). Introduction of a single carboxylic acid converts the cyclic oligomeric depsipeptide ent-verticilide from a ryanodine receptor 2 (RyR2) inhibitor to RyR2 activator. Molecular Pharmacology, 107(12), 100086. https://doi.org/10.1016/j.molpha.2025.100086

Vancouver

Do TQ, Blackwell DJ, Smith AN, Thorpe MP, Rebbeck RT, Laver DR, et al. Introduction of a single carboxylic acid converts the cyclic oligomeric depsipeptide ent-verticilide from a ryanodine receptor 2 (RyR2) inhibitor to RyR2 activator. Molecular Pharmacology. 2025;107(12):100086. doi:10.1016/j.molpha.2025.100086

BibTeX
@article{Do2025,
  author = {Do, Tri Q and Blackwell, Daniel J and Smith, Abigail N and Thorpe, Madelaine P and Rebbeck, Robyn T and Laver, Derek R and Johnston, Jeffrey N and Knollmann, Björn C},
  title = {Introduction of a single carboxylic acid converts the cyclic oligomeric depsipeptide ent-verticilide from a ryanodine receptor 2 (RyR2) inhibitor to RyR2 activator},
  journal = {Molecular Pharmacology},
  year = {2025},
  volume = {107},
  number = {12},
  pages = {100086},
  doi = {10.1016/j.molpha.2025.100086}
}
Kostenlos starten →